Einzeltreffer — DigiBib

Background: This study aimed to determine native T1 and extracellular volume fraction (ECV) in distinct types of myocardial disease, including amyloidosis, dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), myocarditis and coronary artery disease (CAD), compared to controls.

Methods: We retrospectively enrolled patients with distinct types of myocardial disease, CAD patients, and control group (no known heart disease and negative CMR study) who underwent 3.0 Tesla CMR with routine T1 mapping. The region of interest (ROI) was drawn in the myocardium of the mid left ventricular (LV) short axis slice and at the interventricular septum of mid LV slice. ECV was calculated by actual hematocrit (Hct) and synthetic Hct. T1 mapping and ECV was compared between myocardial disease and controls, and between CAD and controls. Diagnostic yield and cut-off values were assessed.

Results: A total of 1188 patients were enrolled. The average T1 values in the control group were 1304 ± 42 ms at septum, and 1294 ± 37 ms at mid LV slice. The average T1 values in patients with myocardial disease and CAD were significantly higher than in controls (1441 ± 72, 1349 ± 59, 1345 ± 59, 1355 ± 56, and 1328 ± 54 ms for septum of amyloidosis, DCM, HCM, myocarditis, and CAD). Native T1 of the mid LV level and ECV at septum and mid LV with actual and synthetic Hct of patients with myocardial disease or CAD were significantly higher than in controls.

Conclusions: Although native T1 and ECV of patients with cardiomyopathy and CAD were significantly higher than controls, the values overlapped. The greatest clinical utilization was found for the amyloidosis group.

Titel:	Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
Autor/in / Beteiligte Person:	Thongsongsang, R ; Songsangjinda, T ; Tanapibunpon, P ; Krittayaphong, R
Link:	View record at Springer (Volltext)
Zeitschrift:	BMC cardiovascular disorders, Jg. 21 (2021-06-03), Heft 1, S. 270
Veröffentlichung:	London : BioMed Central, [2001-, 2021
Medientyp:	academicJournal
ISSN:	1471-2261 (electronic)
DOI:	10.1186/s12872-021-02086-3
Schlagwort:	Adult Aged Aged, 80 and over Amyloidosis diagnostic imaging Amyloidosis pathology Cardiomyopathies pathology Cardiomyopathy, Dilated diagnostic imaging Cardiomyopathy, Dilated pathology Cardiomyopathy, Hypertrophic diagnostic imaging Cardiomyopathy, Hypertrophic pathology Coronary Artery Disease pathology Diagnosis, Differential Female Fibrosis Humans Male Middle Aged Predictive Value of Tests Retrospective Studies Cardiomyopathies diagnostic imaging Coronary Artery Disease diagnostic imaging Magnetic Resonance Imaging, Cine Myocardium pathology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [BMC Cardiovasc Disord] 2021 Jun 03; Vol. 21 (1), pp. 270. <i>Date of Electronic Publication: </i>2021 Jun 03. MeSH Terms: Magnetic Resonance Imaging, Cine* ; Cardiomyopathies / diagnostic imaging ; Coronary Artery Disease / diagnostic imaging ; Myocardium / *pathology ; Adult ; Aged ; Aged, 80 and over ; Amyloidosis / diagnostic imaging ; Amyloidosis / pathology ; Cardiomyopathies / pathology ; Cardiomyopathy, Dilated / diagnostic imaging ; Cardiomyopathy, Dilated / pathology ; Cardiomyopathy, Hypertrophic / diagnostic imaging ; Cardiomyopathy, Hypertrophic / pathology ; Coronary Artery Disease / pathology ; Diagnosis, Differential ; Female ; Fibrosis ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies References: J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. (PMID: 28992817) ; JACC Cardiovasc Imaging. 2015 Jan;8(1):37-46. (PMID: 25499131) ; J Cardiovasc Magn Reson. 2013 Oct 14;15:92. (PMID: 24124732) ; J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176. (PMID: 30545455) ; J Am Coll Cardiol. 2013 Aug 27;62(9):826-38. (PMID: 23727209) ; Cardiovasc Diagn Ther. 2014 Apr;4(2):126-37. (PMID: 24834410) ; Magn Reson Insights. 2019 May 01;12:1178623X19843519. (PMID: 31068754) ; JAMA Cardiol. 2020 Dec 1;5(12):1401-1409. (PMID: 32745166) ; J Cardiovasc Magn Reson. 2014 Oct 21;16:69. (PMID: 25384607) ; Med Image Anal. 2019 Feb;52:212-227. (PMID: 30597459) ; Int J Cardiovasc Imaging. 2002 Feb;18(1):539-42. (PMID: 12135124) ; Circulation. 2005 Jan 18;111(2):186-93. (PMID: 15630027) ; J Cardiovasc Magn Reson. 2020 Sep 7;22(1):63. (PMID: 32892751) ; JACC Cardiovasc Imaging. 2017 Nov;10(11):1402-1404. (PMID: 28216005) ; J Cardiovasc Magn Reson. 2017 Sep 28;19(1):74. (PMID: 28954631) ; JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97. (PMID: 23498672) ; Circ Cardiovasc Imaging. 2016 Dec;9(12):. (PMID: 27974408) ; J Am Coll Cardiol. 2006 Apr 4;47(7):1427-32. (PMID: 16580532) ; J Cardiovasc Magn Reson. 2019 Aug 29;21(1):54. (PMID: 31462282) ; J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. (PMID: 19389557) ; Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):597-602. (PMID: 24566951) ; J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89. (PMID: 27899132) ; Magn Reson Med. 2012 Jun;67(6):1644-55. (PMID: 22135227) ; Adv Drug Deliv Rev. 2019 Jun;146:77-82. (PMID: 31158407) ; Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):980-987. (PMID: 28329376) ; Circ J. 2015;79(3):487-94. (PMID: 25746524) ; JACC Cardiovasc Imaging. 2013 Sep;6(9):955-62. (PMID: 23582361) ; Eur J Radiol. 2018 Dec;109:235-247. (PMID: 30539759) ; JACC Cardiovasc Imaging. 2016 Jan;9(1):40-50. (PMID: 26762873) ; JACC Cardiovasc Imaging. 2016 Jan;9(1):27-36. (PMID: 26684978) ; Circ Res. 2016 Jul 8;119(2):277-99. (PMID: 27390332) ; AJR Am J Roentgenol. 2010 Dec;195(6):W394-9. (PMID: 21098170) ; Quant Imaging Med Surg. 2015 Aug;5(4):503-10. (PMID: 26435913) ; JACC Cardiovasc Imaging. 2013 Apr;6(4):475-84. (PMID: 23498674) ; Heart. 2013 Jul;99(13):932-7. (PMID: 23349348) ; J Am Coll Cardiol. 2016 Jun 28;67(25):2996-3010. (PMID: 27339497) ; PLoS One. 2016 May 24;11(5):e0155591. (PMID: 27219329) ; Heart Fail Rev. 2018 Sep;23(5):723-731. (PMID: 29968223) ; J Cardiovasc Magn Reson. 2015 May 10;17:33. (PMID: 25958014) ; J Am Coll Cardiol. 2018 Mar 6;71(9):957-968. (PMID: 29495995) ; Eur Heart J. 2014 Oct 14;35(39):2733-79. (PMID: 25173338) Contributed Indexing: Keywords: Extracellular volume fraction; T1 mapping; cardiomyopathy; myocardial disease Entry Date(s): Date Created: 20210604 Date Completed: 20220103 Latest Revision: 20220103 Update Code: 20240513 PubMed Central ID: PMC8173747

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.